Shopping Cart 0
Cart Subtotal
AED 0

Ampio Pharmaceuticals Inc (AMPE)-Medical Equipment-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Ampio Pharmaceuticals Inc (Ampio), formerly Chay Enterprises Inc is a biopharmaceutical company that discovers and develops novel therapeutic candidates for inflammatory conditions. The company provides products for the treatment of osteoarthritis of the knee and diabetic macular edema. Its products include low molecular weight fraction of human serum albumin and ultra-low dose of danazol. Ampio's ultra-low dose of danazol is used for the oral treatment of diabetic macular edema. The company is conducting research on various future indications for optina. It partners with other biopharmaceutical companies for its research activities. Ampio is headquartered in Englewood, Colorado, the US.

Ampio Pharmaceuticals Inc (AMPE)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company financial deals that enable you to understand the company expansion/divestiture and fund requirements

The profile enables you to analyze the company financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company business segments' expansion / divestiture strategy

The profile presents deals from the company core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Ampio Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8

Ampio Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Ampio Pharmaceuticals Inc, Medical Equipment, Deal Details 10

Asset Purchase 10

Ampio Pharma Completes Acquisition Of Rights Of Drug Delivery Technology From Valeant International 10

Venture Financing 11

Luoxis Diagnostics To Raise US$5 Million In Venture Financing 11

Merger 11

Rosewind Merges with Vyrix Pharma and Luoxis Diagnostics in Reverse Merger Transaction 11

Equity Offering 12

Ampio Pharma Completes Public Offering Of Shares For US$68.4 Million 12

Ampio Pharma Completes Private Placement Of Shares For US$25.3 Million 13

Ampio Pharma Completes First Tranche Of Private Placement Of Shares 14

Ampio Pharmaceuticals Inc-Key Competitors 16

Key Employees 17

Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

Corporate Communications 19

Jun 12, 2017: Ampio Announces Appointment of Interim Chief Financial Officer 19

Other Significant Developments 20

Mar 20, 2017: Ampio Pharmaceuticals Provides Corporate Update 20

Appendix 21

Methodology 21

About GlobalData 21

Contact Us 21

Disclaimer 21


List Of Figure

List of Figures

Ampio Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Ampio Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6

Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Ampio Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8


List Of Table

List of Tables

Ampio Pharmaceuticals Inc, Medical Equipment, Key Facts, 2016 1

Ampio Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Ampio Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Ampio Pharmaceuticals Inc, Deals By Market, 2011 to YTD 2017 8

Ampio Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Ampio Pharma Completes Acquisition Of Rights Of Drug Delivery Technology From Valeant International 10

Luoxis Diagnostics To Raise US$5 Million In Venture Financing 11

Rosewind Merges with Vyrix Pharma and Luoxis Diagnostics in Reverse Merger Transaction 11

Ampio Pharma Completes Public Offering Of Shares For US$68.4 Million 12

Ampio Pharma Completes Private Placement Of Shares For US$25.3 Million 13

Ampio Pharma Completes First Tranche Of Private Placement Of Shares 14

Ampio Pharmaceuticals Inc, Key Competitors 16

Ampio Pharmaceuticals Inc, Key Employees 17

Ampio Pharmaceuticals Inc, Subsidiaries 18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Ampio Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Ampio Pharmaceuticals Inc (Ampio), formerly Chay Enterprises Inc is a biopharmaceutical company that discovers and develops novel therapeutic candidates for inflammatory conditions. The company provides products for the treatment of osteoarthritis of the knee and diabetic macular edema. Its products include low molecular weight fraction of human serum albumin and ultra-low dose of danazol. Ampio's ultra-low dose of danazol is used for the oral treatment of diabetic macular edema. The company is conducting research on various future indications for optina. It partners with other biopharmaceutical companies for its research activities. Ampio is headquartered in Englewood, Colorado, the US.

Ampio Pharmaceuticals Inc (AMPE)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company financial deals that enable you to understand the company expansion/divestiture and fund requirements

The profile enables you to analyze the company financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company business segments' expansion / divestiture strategy

The profile presents deals from the company core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Ampio Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8

Ampio Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Ampio Pharmaceuticals Inc, Medical Equipment, Deal Details 10

Asset Purchase 10

Ampio Pharma Completes Acquisition Of Rights Of Drug Delivery Technology From Valeant International 10

Venture Financing 11

Luoxis Diagnostics To Raise US$5 Million In Venture Financing 11

Merger 11

Rosewind Merges with Vyrix Pharma and Luoxis Diagnostics in Reverse Merger Transaction 11

Equity Offering 12

Ampio Pharma Completes Public Offering Of Shares For US$68.4 Million 12

Ampio Pharma Completes Private Placement Of Shares For US$25.3 Million 13

Ampio Pharma Completes First Tranche Of Private Placement Of Shares 14

Ampio Pharmaceuticals Inc-Key Competitors 16

Key Employees 17

Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

Corporate Communications 19

Jun 12, 2017: Ampio Announces Appointment of Interim Chief Financial Officer 19

Other Significant Developments 20

Mar 20, 2017: Ampio Pharmaceuticals Provides Corporate Update 20

Appendix 21

Methodology 21

About GlobalData 21

Contact Us 21

Disclaimer 21


List Of Figure

List of Figures

Ampio Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Ampio Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6

Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Ampio Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8


List Of Table

List of Tables

Ampio Pharmaceuticals Inc, Medical Equipment, Key Facts, 2016 1

Ampio Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Ampio Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Ampio Pharmaceuticals Inc, Deals By Market, 2011 to YTD 2017 8

Ampio Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Ampio Pharma Completes Acquisition Of Rights Of Drug Delivery Technology From Valeant International 10

Luoxis Diagnostics To Raise US$5 Million In Venture Financing 11

Rosewind Merges with Vyrix Pharma and Luoxis Diagnostics in Reverse Merger Transaction 11

Ampio Pharma Completes Public Offering Of Shares For US$68.4 Million 12

Ampio Pharma Completes Private Placement Of Shares For US$25.3 Million 13

Ampio Pharma Completes First Tranche Of Private Placement Of Shares 14

Ampio Pharmaceuticals Inc, Key Competitors 16

Ampio Pharmaceuticals Inc, Key Employees 17

Ampio Pharmaceuticals Inc, Subsidiaries 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Ampio Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.